DNLI
Denali Therapeutics Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -4.1% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +6 | 103.66M | $2.65B | +11 | −4 |
| Q1 2026 | 93 | +4 | 96.77M | $1.85B | +11 | −8 |
| Q4 2025 | 89 | 0 | 110.68M | $1.83B | +1 | — |
| Q3 2025 | 19 | 0 | 67.26M | $976.61M | — | −1 |
| Q2 2025 | 17 | +1 | 74.76M | $1.05B | +2 | −1 |
| Q1 2025 | 13 | +1 | 44.98M | $611.55M | +2 | −1 |
| Q4 2024 | 12 | -1 | 38.31M | $780.78M | — | −1 |
| Q3 2024 | 12 | 0 | 34.10M | $993.27M | +1 | −1 |
| Q2 2024 | 12 | — | 35.56M | $825.78M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 13.35M | -3.0% | $388.77M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 13.35M | -3.0% | $388.77M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 13.35M | -3.0% | $388.77M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 13.35M | -3.0% | $388.77M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 10.73M | +9.2% | $312.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 10.73M | +9.2% | $312.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 10.73M | +9.2% | $312.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 10.73M | +9.2% | $312.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 10.73M | +9.2% | $312.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 10.73M | +9.2% | $312.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 10.73M | +9.2% | $312.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasif) | 2.96M | -0.9% | $86.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Geode Capital Management ✦ (pasif) | 2.96M | -0.9% | $86.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 2.87M | +27.2% | $83.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 2.87M | +27.2% | $83.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 1.97M | -18.7% | $57.30M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 777.28K | -36.2% | $22.64M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 547.33K | +14.5% | $15.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Norges Bank ✦ (pasif) | 397.54K | -51.8% | $11.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 333.53K | -68.3% | $9.72M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 99.47K | +4.8% | $2.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Millennium Management ✦ | 60.17K | -90.3% | $1.75M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 16.02K | Baru | $466,605 | 0.0% | New | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 16.02K | Baru | $466,605 | 0.0% | New | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 16.02K | Baru | $466,605 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| AQR Capital Management | $466,605 | 0.0% |
| AQR Capital Management | $466,605 | 0.0% |
| AQR Capital Management | $466,605 | 0.0% |
Telah keluar
| D. E. Shaw & Co. | $690,122 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 265 pemegang, 147.10M saham, $2.60B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 2.86K lbr · $71,625
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi